Cost analysis of laparoscopic total versus open total gastrectomy in gastric cancer
- PMID: 39776257
- PMCID: PMC11711782
- DOI: 10.1007/s00423-024-03562-y
Cost analysis of laparoscopic total versus open total gastrectomy in gastric cancer
Abstract
Purpose: Despite ongoing discussions concerning clinical equivalence of laparoscopic total gastrectomy (LTG) compared to open total gastrectomy (OTG) in gastric cancer (GC) surgery, complementary evidence regarding financial implications is sparse. The aim of this study was to compare hospital associated expenses and perioperative outcomes between both approaches.
Methods: Clinicopathological and financial data from 80 consecutive GC patients undergoing LTG or OTG between 2015 and 2022 were investigated. Patient baseline characteristics, perioperative results, long-term outcomes and financial expenses up to 30 days after discharge were compared. A binary logistic regression model to identify individual cost drivers was performed.
Results: LTG was associated with significantly prolonged operating time (281 min vs. 245 min, p < 0.02). However, LTG demonstrated a trend towards lower total (18,708 € vs. 22,810 €, p = 0.11) and median daily (1,516 € vs. 1,721 €, p = 0.25) expenses, yet not reaching statistical significance. Decreased ICU costs emerged as the greatest single cost reducer in LTG (962 € vs. 2,147 €, p = 0.10). Hospital length of stay ≥ 15 days was the only independent cost driver for increased expenses (HR [95% CI] = 13,2 [3.0-58.9], p < 0.01). Ultimately, patients undergoing LTG and OTG demonstrated similar outcomes in terms of perioperative morbidity (n = 8, 13% vs. n = 3, 17%, p = 0.70), median number of resected lymph nodes (n = 32 vs. n = 33, p = 0.72), absence of 90-day mortality, and long-term survival (p = 0.47).
Conclusion: Although typically involving longer operating times, LTG tends to be linked with decreased hospital costs, yet not reaching statistical significance. The ongoing establishment of LTG seems not to pose additional financial burdens for surgical departments.
Keywords: Cost analysis; Laparoscopic surgery; Total gastrectomy; Upper gastrointestinal surgery.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Laparoscopic versus open total gastrectomy for T4a gastric cancer: a propensity score-matched analysis of long-term outcomes.Updates Surg. 2024 Sep;76(5):1843-1854. doi: 10.1007/s13304-024-01910-7. Epub 2024 Jun 16. Updates Surg. 2024. PMID: 38879836
-
[Comparison of early clinical outcomes between laparoscopic total gastrectomy and open total gastrectomy for early-stage gastric cancer].Gan To Kagaku Ryoho. 2014 Nov;41(12):1476-8. Gan To Kagaku Ryoho. 2014. PMID: 25731224 Japanese.
-
Comparison of short-term surgical outcomes between laparoscopic and open total gastrectomy for gastric carcinoma: case-control study using propensity score matching method.J Am Coll Surg. 2013 Feb;216(2):184-91. doi: 10.1016/j.jamcollsurg.2012.10.014. Epub 2012 Dec 2. J Am Coll Surg. 2013. PMID: 23211117
-
Laparoscopic total gastrectomy as a valid procedure to treat gastric cancer option both in early and advanced stage: A systematic review and meta-analysis.Eur J Surg Oncol. 2020 Jan;46(1):33-43. doi: 10.1016/j.ejso.2019.08.018. Epub 2019 Aug 23. Eur J Surg Oncol. 2020. PMID: 31477462
-
Laparoscopic vs open total gastrectomy for gastric cancer: a meta-analysis.World J Gastroenterol. 2013 Nov 28;19(44):8114-32. doi: 10.3748/wjg.v19.i44.8114. World J Gastroenterol. 2013. PMID: 24307808 Free PMC article. Review.
References
-
- National Comprehensive Cancer Network (2019) Gastric cancer (version 2.2022). Published
-
- Al-Batran SE, Hofheinz RD, Pauligk C et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393(10184):1948–1957. 10.1016/S0140-6736(18)32557-1 - PubMed
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. JAMA Oncol 7(6):819–841. 10.1001/jamaoncol.2020.2836 - PubMed
-
- Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 4:146–148. 10.1097/00019509-199406000-00008 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous